Molecules (Jun 2021)

Mechanistic Actions between <i>Garcinia atroviridis</i> Essential Oil and 2 Deoxy-<span style="font-variant: small-caps">d</span>-glucose in Cultured PANC-1 Human Pancreatic Cancer Cells

  • Nik Nur Syazni Nik Mohamed Kamal,
  • Fatin Athirah Abdul Aziz,
  • Wen-Nee Tan,
  • Agustine Nengsih Fauzi,
  • Vuanghao Lim

DOI
https://doi.org/10.3390/molecules26123518
Journal volume & issue
Vol. 26, no. 12
p. 3518

Abstract

Read online

Pancreatic cancer is an aggressive disease that progresses in a relatively symptom-free manner; thus, is difficult to detect and treat. Essential oil is reported to exhibit pharmacological properties, besides its common and well-known function as aromatherapy. Therefore, this study herein aimed to investigate the anti-proliferative effect of essential oil extracted from leaves of Garcinia atroviridis (EO-L) against PANC-1 human pancreatic cancer cell line. The cell growth inhibitory concentration at 50% (IC50) and selective index (SI) values of EO-L analyses were determined as 78 µg/mL and 1.23, respectively. Combination index (CI) analysis revealed moderate synergism (CI values of 0.36 to 0.75) between EO-L and 2 deoxy-d-glucose (2-DG) treatments. The treatments of PANC-1 cells with EO-L, 2-DG and EOL+2DG showed evidence of depolarization of mitochondrial membrane potential, cell growth arrest and apoptosis. The molecular mechanism causing the anti-proliferative effect between EO-L and 2-DG is potentially through pronounced up-regulation of P53 (4.40-fold), HIF1α (1.92-fold), HK2 (2.88-fold) and down-regulation of CYP3A5 (0.11-fold), as supported by quantitative mRNA expression analysis. Collectively, the current data suggest that the combination of two anti-proliferative agents, EO-L and 2-DG, can potentially be explored as therapeutic treatments and as potentiating agents to conventional therapy against human pancreatic cancer.

Keywords